
Early T cell immunodynamics in blood
Prof Dr Lieve Brochez from the University Hospital Gent, Belgium, presented research from the Skin Cancer Research Institute Gent at the EADO 2025 meeting in Athens. The focus was on
MediMix aims to bring high value medical information to Belgian healthcare professionals via multiple channels. Our team covers congresses and symposia all over the world. In collaboration with Belgian and international experts, we bring the newest data in several different formats to Belgian physicians.
Latest publications
Prof Dr Lieve Brochez from the University Hospital Gent, Belgium, presented research from the Skin Cancer Research Institute Gent at the EADO 2025 meeting in Athens. The focus was on
At the 2025 EADO Congress, Prof Dr Georgina Long and Prof Dr Bart Neyns share perspectives on the evolving role of neoadjuvant immunotherapy in resectable stage III melanoma. While not
Prof Dr Mireille Fontsa Langouo provides some key insights into treating acral
lentiginous melanoma (ALM). She also emphasises the emerging role of
biomarkers in predicting patient response and
Dr Bart Appeltans, an oncologic surgeon at the Jessa Hospital in Hasselt, Belgium, discussed some interesting novelties in melanoma surgery.
Dr Vincent Geldhof discussed some interesting novelties in melanoma treatment. These promising developments focused on novel immunotherapies, treatment strategies for BRAF-mutated melanoma, and updated insights into therapy-related toxicity.